Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-10-17 | 2023-01-12 | 172013 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-10-28 | 2023-01-12 | 173061 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-11-14 | 2023-01-12 | 174586 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174589 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179306 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210428 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211982 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 211988 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211992 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-12-14 | 2024-02-01 | 213371 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2019-10-17 | 2020-03-26 | 96720 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2022-12-01 | 2022-12-15 | 176785 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2019-11-28 | 2020-03-05 | 99941 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2020-09-03 | 2020-12-03 | 123720 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173010 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |